Citius Pharmaceuticals Inc (NASDAQ:CTXR) traded at $1.03 at close of the session on Monday, June 23 and made a downward move of -4.63%% on its previous day’s price.
Looking at the stock we see that its previous close was $1.08 and the beta (5Y monthly) reads 0.852 with the day’s price range being $0.969 – $1.25. In terms of its 52-week price range, CTXR has a high of $26.25 and a low of $0.65. The company’s stock has gained about 51.25% over that past 30 days.
Citius Pharmaceuticals Inc has a market cap of $11.51 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the CTXR stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Citius Pharmaceuticals Inc (CTXR) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 16.93% off its SMA20 and 21.61% from its 50-day simple moving average. The RSI (14) is pointing at 55.66 while the volatility over the past week is 8.85% and jumps to 14.21% over the past one month.
Coming back to Citius Pharmaceuticals Inc (NASDAQ:CTXR), we note that the average 3-month trading volume was 2.15 million, while that of the preceding 10-day period stands at 11.83 million. Current shares outstanding are 11.17 million.
The insiders hold 5.74% of the company’s shares while institutions hold 5.69%. The data shows that short shares as of 2025-05-30, stood at 0.66 million at a short ratio of 4.54. This represents a 678.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 0.67 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -93.25% down in year-to-date price movement.
